Mounjaro and Ozempic are two of the most recognised names in the world of injectable medications for diabetes and weight management. Both have generated huge public interest, especially as more people look for effective ways to support long-term weight loss. At Right Medicine Pharmacy, we see a growing demand for these weight loss treatments across Scotland. One of the most common questions we hear is about availability: how easy is it to access Mounjaro vs Ozempic in the UK? The answer is different for each medication and depends on whether you are looking for NHS or private treatment.
Ozempic: NHS Availability
Ozempic contains semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes. On the NHS, it is licensed and prescribed for managing diabetes when lifestyle measures and other treatments are not enough. Patients with type 2 diabetes may be offered Ozempic if it is clinically appropriate and approved by their GP or specialist.
However, for people who do not have diabetes and are looking for help with weight management, Ozempic is not available through the NHS. There have also been significant supply challenges, which means prescribers are prioritising diabetic patients who need the medication for blood sugar control.
Wegovy vs Ozempic
Many people confuse Ozempic with Wegovy because both contain semaglutide. The key difference is in their licensing. Wegovy is the brand licensed specifically for weight loss. It is gradually becoming available in the UK, including through limited NHS pathways for patients who meet strict criteria, usually under specialist weight management services. For others, Wegovy is accessible privately, though demand continues to outstrip supply.
Ozempic, on the other hand, is not licensed for weight loss in the UK, even though it has been used off-label for that purpose in some countries. This distinction is important when comparing Mounjaro vs Ozempic for patients considering their options.
Mounjaro: A Private Option For Weight Management
Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. It is newer than Ozempic and has shown strong results in clinical trials for both diabetes and weight loss. In the UK, Mounjaro is licensed for type 2 diabetes treatment, but it is already being offered privately at pharmacies and clinics for weight management.
At Right Medicine Pharmacy, we provide access to Mounjaro through our weight loss clinics in Scotland, following private consultations to ensure it is safe and appropriate for each patient. Unlike Ozempic, which is restricted by NHS guidance and supply issues, Mounjaro is becoming more commonly used in private settings as part of structured weight management programmes.
NHS vs Private Access
When comparing Mounjaro vs Ozempic in terms of UK availability, the NHS route is clear. Ozempic is reserved for type 2 diabetes patients, and Mounjaro is also currently focused on diabetes care under NHS prescribing rules. Wegovy is the designated NHS option for weight loss, but with very limited access.
For people who are overweight or obese and do not have diabetes, the reality is that private clinics and pharmacies are often the only practical route to access these medications. This is where Mounjaro stands out, as it is being prescribed more widely in the private sector for weight management than Ozempic.
Why Professional Guidance Matters
Although availability is a big part of the discussion, safety and suitability are just as important. Both Mounjaro and Ozempic can cause side effects, especially during the early stages or dose increases. Nausea, diarrhoea, and constipation are among the most common issues. These can usually be managed, but they highlight why professional oversight is essential.
At our clinics, we do not simply dispense medication. We combine prescriptions with advice on nutrition, physical activity, and lifestyle habits, ensuring patients have the tools they need for sustainable weight loss. This structured support makes the difference between short-term results and long-term success.
Choosing Between Mounjaro And Ozempic
If you are living with type 2 diabetes, your GP or NHS diabetes service may discuss Ozempic or Mounjaro with you depending on your clinical needs. For weight management without diabetes, however, Ozempic is not an option on the NHS. Wegovy may be available in certain circumstances, but supply is limited and waiting lists are long.
This leaves private care as the most accessible route for many people, and Mounjaro is currently one of the most promising choices. Its unique dual mechanism and proven weight loss outcomes make it an effective tool, particularly when paired with professional guidance and lifestyle adjustments.
Moving Forward With Confidence
The discussion around Mounjaro vs Ozempic in the UK highlights a key point: while both are valuable treatments, their availability differs significantly. Ozempic remains primarily for type 2 diabetes under NHS care, while Mounjaro is becoming a more practical private weight loss option at pharmacies like ours in Scotland.
At Right Medicine Pharmacy, we aim to provide clear information and accessible weight management services. If you are considering medication as part of your journey, booking a consultation with our team ensures you receive safe, personalised advice. Contact us to find out more, or book using the form below:
[bookly-form category_id=”-1″ service_id=”4″]
With the right plan, you can approach weight loss with confidence and the support you need.
This blog was written on behalf of Right Medicine Pharmacy by Pharmacy Mentor.
